位置:首页 > 蛋白库 > ECDI_ASPRU
ECDI_ASPRU
ID   ECDI_ASPRU              Reviewed;         559 AA.
AC   K0E2F3;
DT   25-APR-2018, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2012, sequence version 1.
DT   03-AUG-2022, entry version 22.
DE   RecName: Full=Fatty-acyl-AMP ligase ecdI {ECO:0000303|PubMed:22998630};
DE            EC=6.2.1.- {ECO:0000305|PubMed:22998630};
DE   AltName: Full=Echinocandin B biosynthetic cluster protein I {ECO:0000303|PubMed:22998630};
GN   Name=ecdI {ECO:0000303|PubMed:22998630};
OS   Aspergillus rugulosus (Emericella rugulosa).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus.
OX   NCBI_TaxID=41736;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, PATHWAY, AND BIOTECHNOLOGY.
RC   STRAIN=ATCC 58397 / NRRL 11440;
RX   PubMed=22998630; DOI=10.1021/ja307220z;
RA   Cacho R.A., Jiang W., Chooi Y.H., Walsh C.T., Tang Y.;
RT   "Identification and characterization of the echinocandin B biosynthetic
RT   gene cluster from Emericella rugulosa NRRL 11440.";
RL   J. Am. Chem. Soc. 134:16781-16790(2012).
CC   -!- FUNCTION: Fatty-acyl-AMP ligase; part of the gene cluster that mediates
CC       the biosynthesis of echinocandin B, a fungal lipidated cyclic
CC       hexapeptide that acts as an antifungal agent (PubMed:22998630).
CC       Linoleoyl-AMP, produced by the fatty-acyl-AMP ligase ecdI, is
CC       transferred to the initiation carrier domain (T0) of ecdA
CC       (PubMed:22998630). The linoleoyl-S-phosphopantetheinyl-T0 is
CC       sequentially extended with L-ornithine, L-threonine, L-proline, L-
CC       homotyrosine, L-threonine, and 4R-methyl-L-proline to form the linear
CC       hexapeptide (PubMed:22998630). Thereafter, the terminal condensation
CC       (C7) performs macrocyclization of the NRPS product and the cyclic
CC       scaffold is released from ecdA (PubMed:22998630). All six of the amino
CC       acid residues are hydroxylated, including 4R,5R-dihydroxy-L-ornithine,
CC       4R-hydroxyl-L-proline, 3S,4S-dihydroxy-L-homotyrosine, and 3S-hydroxyl-
CC       4S-methyl-L-prolin (PubMed:22998630). In the pathway, all the
CC       hydroxylation reactions are proposed to occur following completion of
CC       the cyclic peptide, so the unhydroxylated precursor produced by ecdA
CC       will undergo six rounds of hydroxylation (PubMed:22998630). Five
CC       hydroxylase genes (ecdG, ecdH, ecdK, htyE and htyF) are embedded within
CC       the echinocandin B (ecd) and L-homotyrosine (hty) clusters
CC       (PubMed:22998630). {ECO:0000269|PubMed:22998630}.
CC   -!- PATHWAY: Antifungal biosynthesis. {ECO:0000269|PubMed:22998630}.
CC   -!- DOMAIN: Both substrate-binding domains (SBD1 and SBD2) are involved in
CC       the substrate recognition, and are sufficient to confer the substrate
CC       specificity. {ECO:0000250|UniProtKB:Q42524}.
CC   -!- BIOTECHNOLOGY: Due to their effectiveness as antifungal agents,
CC       echinocandin derivatives can be used for the treatment of human
CC       invasive candidiasis (PubMed:22998630). {ECO:0000269|PubMed:22998630}.
CC   -!- SIMILARITY: Belongs to the ATP-dependent AMP-binding enzyme family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; JX421684; AFT91380.1; -; Genomic_DNA.
DR   AlphaFoldDB; K0E2F3; -.
DR   SMR; K0E2F3; -.
DR   BioCyc; MetaCyc:MON-19232; -.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016874; F:ligase activity; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.300.30; -; 1.
DR   Gene3D; 3.40.50.12780; -; 1.
DR   InterPro; IPR025110; AMP-bd_C.
DR   InterPro; IPR045851; AMP-bd_C_sf.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   InterPro; IPR042099; ANL_N_sf.
DR   Pfam; PF00501; AMP-binding; 1.
DR   Pfam; PF13193; AMP-binding_C; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Glycoprotein; Ligase; Nucleotide-binding.
FT   CHAIN           1..559
FT                   /note="Fatty-acyl-AMP ligase ecdI"
FT                   /id="PRO_0000443832"
FT   REGION          278..348
FT                   /note="SBD1"
FT                   /evidence="ECO:0000250|UniProtKB:Q42524"
FT   REGION          349..411
FT                   /note="SBD2"
FT                   /evidence="ECO:0000250|UniProtKB:Q42524"
FT   BINDING         207..215
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q08AH3"
FT   BINDING         348..353
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q08AH3"
FT   BINDING         432
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q08AH3"
FT   BINDING         451
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q08AH3"
FT   BINDING         549
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q08AH3"
FT   CARBOHYD        30
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        223
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
SQ   SEQUENCE   559 AA;  60785 MW;  5C497D7FC2A205C1 CRC64;
     MVFTSPAWCS QLASTIPETK LVGDFVLEGN GTESGDKPLL VCAETGKSYN IGVLENRVDL
     LARSLMRVFG WSPNEGAPED KVVGICSFNA MDFVPLSWAI HRVGGICLVL HPTSSAAELQ
     SLMRQASCKA LFTCRDLLPT CRAVLEALKL ESSRLFLLEL PADEQTTQAQ PVSVSQLIAD
     GESLPPVDKV ALQDGESKHR VAYLCPTSGT SGYQKLAQIT HKNITSNILQ AVTLDGFATR
     TAPEVALGIL PLSHAYGLVA FSTLLYRRDT VILHARFDMP AALRSIQQYR IQRLYVVPAI
     VAALVNNPIL FKLADLSSVQ SLIVGSAPLS KELVGALKRV RPEWDLLAGY GLTEAAVFVS
     CTSKHSIFPG SVGSLLPHVE ARLVGDDGAE IQDYDVAGEL FLRSPSIMKG YLVDDATDSG
     AFDADGWLIT GDVASFRKGP DGEEHLFIVD RKKDIMKVKG IQVAPAEIET RLLSHPAVDE
     AAVFGINDAE AGERPFAFVV RSKMVNVDLD EKALRQSIHS HIQETLSEPF WLRDNIKFVE
     SIPKGHSGKA LKFKLKELI
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024